BackEuda Health Holdings Limited - Warrants (17/11/2027) Overview
Euda Health Holdings Limited - Warrants (17/11/2027)

Euda Health Holdings Limited - Warrants (17/11/2027) Return on Equity

Valuation check: EUDAW's ROE is -39.56%, below the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

-39.56%

Return on Equity

-39.56%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Euda Health Holdings Limited - Warrants (17/11/2027) (EUDAW) FAQ

Euda Health Holdings Limited - Warrants (17/11/2027) (EUDAW) currently reports a ROE of -39.56%. That is below the sector sector average of 11.3%. Use the charts on this page to explore Euda Health Holdings Limited - Warrants (17/11/2027)'s ROE history and peer comparisons.

Euda Health Holdings Limited - Warrants (17/11/2027)'s ROE of -39.56% is lower than the its sector sector average of 11.3%. That is roughly 450.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Euda Health Holdings Limited - Warrants (17/11/2027)'s current -39.56% should be judged against industry norms (sector average: 11.3%) and against EUDAW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -39.56%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.3%. From there, open related valuation or income-statement pages for Euda Health Holdings Limited - Warrants (17/11/2027), and consider following EUDAW for alerts when major investors trade the stock.